AAV-CreERT2 (AAV serotype 9) AAV

Name 
AAV9-CreERT2
Cat No 
7114
Availability
Immediate

A mutated form of estrogen ligand-binding domain (ERT2) that binds to synthetic antagonists (such as tamoxifen or its derivative 4-hydroxy-tamoxifen) but not to circulating estrogens was fused to the Cre recombinase (Cre) to create the CreERT2, which requires the presence of tamoxifen for Cre recombinase activity. Therefore it makes possible to induce the recombination in cells with tamoxifen.

This AAV-9 virus expresses CreERT2 under a CMV promoter.

7114
AAV9-CreERT2

Ready-to-use AAV-CreERT2 (AAV serotype 9). 7114 AAV9-CreERT2 AAV-CreERT2

$495.00
Request Volume Pricing or Customization

Product Details

AAV Serotype
AAV-DJ9
AAV ITR
AAV2
Promoter
CMV (ubiquitous)
Storage Buffer
PBS/5% Glycerol
Titer
1x10^13 GC/ml
Viral Backbone
Recombinant AAV
Volume (µL)
20

About Storage Conditions

All our viral products should be kept at -80°C. At this temperature, the virus will remain stable for 6-12 months (and in some cases, up to 2 years). Once thawed, the product can be stored at 4°C for 2-3 weeks without significant loss of biological activity. We recommend aliquoting your vectors into low protein binding tubes upon receipt. This helps avoid repeated freeze-thaw cycles, as well as prevent loss of virus. To maintain accurate titer, aliquot in at least 20ul per tube.